Clinical trial Recruiting at 1 site Observational

Mental health and quality of life after ICU treatment with dexmedetomidine for electrical storm

Official title: Study Evaluating Dexmedetomidine in the Acute Treatment of Electrical Storm: Outpatient Follow-up of Mental Health INDices (SDATE OF MIND)

Run by Ottawa Heart Institute Research Corporation · NCT07368062 · Data updated 2026-11-12

This follows people treated for electrical storm in the ICU to see if receiving dexmedetomidine is linked to their mental health and quality of life 3–6 months later.

More Mental Health trials

Quick facts

Study typeObservational
SexAll
Enrollment70 (estimated)
SponsorOttawa Heart Institute Research Corporation
Academic / other
Locations1 site (Ottawa, Ontario)
StatusRecruiting
StartedMarch 15, 2025
Main results expectedDecember 2027
Study endsJune 2028
Registry record updatedJuly 1, 2026
Trial IDNCT07368062 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

People who were admitted to an ICU with electrical storm within the past 6 months and who previously participated in the SEDATE trial are eligible.

Probably not a fit

Patients who did not take part in the SEDATE trial, were not admitted to an ICU for electrical storm, or cannot complete follow-up questionnaires are unlikely to benefit directly from this follow-up.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational follow-up of participants from the SEDATE trial who were admitted to an ICU with electrical storm. Consenting participants will complete standardized questionnaires measuring mental health and health-related quality of life between 3 and 6 months after their ICU admission. Each questionnaire takes about 5–15 minutes to complete, and questionnaires may be completed at a scheduled follow-up visit to the University of Ottawa Heart Institute or by other arranged means. The goal is to describe the mental health burden after ICU care and treatments received during electrical storm to inform improvements in post-ICU care.

Why it matters

Potential benefit: If successful, the findings could lead to better post-ICU mental health screening and support for survivors of electrical storm.

How similar studies have gone: Post-ICU mental health problems are well documented in other critical-care populations, but using SEDATE participants to examine links with dexmedetomidine exposure is a relatively novel approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients admitted to an intensive care unit with a diagnosis of electrical storm within the preceding 6 months
* Previous participants in the SEDATE trial (NCT06281977)

Exclusion Criteria:

\- None

Where it's running

  • University of Ottawa Heart Institute
    Ottawa, Ontario, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.